Mediterranean Journal of Pharmacy and Pharmaceutical Sciences
https://app.periodikos.com.br/journal/medjpps/article/doi/10.5281/zenodo.6397651

Mediterranean Journal of Pharmacy and Pharmaceutical Sciences

Editorial

Novel clinical pharmacy practice: extended role and improved competencies

Abdulbaset A. Elfituri, Fathi M. Sherif

Downloads: 0
Views: 75


In health care delivery system, if you are not part of the solution, then you must be part of the problem. Over the last few decades, clinical pharmacy encourages pharmacist and pharmacy support staff to move their focus from product-oriented role towards new direct engagement with patient, to make the most of the benefits that patients obtain from the medicine they take, or the problems they encounter with, their medicines use. In USA, pharmacists’ participation in physician ward rounds was shown to reduce adverse drug events by 78.0% and 66.0% in general medical and intensive care settings [1. 2]. A study covering 1 029 US hospitals indicated that centrally based and patient-specific clinical pharmacy services are associated with reduced mortality rates [3]. The services involved were medicines information, clinical research performed by pharmacist, active pharmacist participation in resuscitation teams and pharmacist undertaking admission medication histories. New pharmacists’ roles in healthcare system around the globe have moved and developed significantly over the past few years, particularly with expansion of scope of practice which allows pharmacist to focus on the clinical aspects of direct patient care [4, 5]. Pharmacist is drug therapy experts of health care team. Therefore, pharmacist, today, is the arbiters of effective and safe use of medicines. Medication therapy management is one of the major areas in which physician more and more rely on pharmacist to benefit their patients.

References

  1. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA (2003) Pharmacists on rounding teams reduce preventable adverse drug events in hospital gen­eral medicine units. Archives of Internal Medicine. 163 (17): 2014-2018. doi: 10.1001/archinte.163.17.2014
  2. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates DW (1999) Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. Journal of the American Medical Association. 282 (3): 267-270. doi: 10.1001/jama.282.3.267
  3. Bond CA, Raehl CL, Franke T (1999) Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 19 (5): 556-564. doi: 10.1592/phco.19.8.556.31531
  4. Hasan MJ, Bachar SC, Rabbani R, Cope RJ, Gim S (2021) Evolution of pharmacy practice and direct patient care roles for pharmacists in Bangladesh. Journal of the American College of Clinical Pharmacy. 4 (6): 718-722. doi.org/ 10.1002/jac5.1429
  5. Carter BL (2017) Evolution of clinical pharmacy in the US and future directions for patient care. Drugs Aging. 33 (3): 169-177. doi: 10.1007/s40266-016-0349-2
  6. Chua SS, Kok LC, Yusof FAM,  Tang GH, Lee SWH, Efendie B, Paraidathathu T (2012) Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings. BioMed Central Health Services Research. (12) 12: 388. doi: 10.1186/1472-6963-12-388
  7. Sherif FM (2017) Nicotine dependence and role of pharmacist in nicotine addiction control. 2 (1): 3-11. doi: 10.21502/ limuj.002.02.2017
  8. Tahaineh L, Wazaify M, Alomoush F, Nasser SA, Alrawashdh N, Abraham I (2019) Physicians’ perceptions, expectations, and experiences of clinical pharmacists in Jordan-2017. International Journal of Clinical Pharmacy. 41 (5): 1193-1201. doi: 10.1007/s11096-019-00884-6
  9. Singh HK, Kennedy GA, Stupans I (2021) The health coaching competency gap - Analysis of pharmacist competency frameworks from Australia, Canada, New Zealand the UK & the USA. Health and Social Care in the Community. 12. doi: 10.1111/hsc.13494
  10. Zhou M, Desborough J, Parkinson A, Douglas K, McDonald D, Boom K (2019) Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences. The International Journal of Pharmacy Practice. 27 (6): 479-489. doi: 10.1111/ijpp.12557

Submitted date:
02/13/2023

Reviewed date:
02/13/2023

Accepted date:
02/13/2023

Publication date:
10/21/2023

65344096a953953d7b21bd62 medjpps Articles
Links & Downloads

Mediterr J Pharm Pharm Sci

Share this page
Page Sections